Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 9;3(3):100237.
doi: 10.1016/j.mcpdig.2025.100237. eCollection 2025 Sep.

Medication Adherence Technologies: A Classification Taxonomy Based on Features

Bincy Baby  1 , Jasdeep Kaur Gill  1 , Sadaf Faisal  2 , Ghada Elba  1 , SooMin Park  1 , Annette McKinnon  3 , Kirk Patterson  3 , Sara J T Guilcher  4 , Feng Chang  1 , Linda Lee  5 , Catherine Burns  6 , Ryan Griffin  7 , Tejal Patel  1   8
Affiliations

Medication Adherence Technologies: A Classification Taxonomy Based on Features

Bincy Baby et al. Mayo Clin Proc Digit Health. .

Abstract

Objective: To develop a comprehensive classification system for medication adherence technologies based on an inventory of characteristics and features of existing technology.

Participants and methods: Using a 3-stage approach methodology-development, validation, and evaluation, the study adopted the taxonomy development method and was conducted from February 1, 2023 to July 31, 2024. In the development stage, medication adherence technologies were defined, end users were identified, and a meta-characteristic was determined; using both empirical-to-conceptual and conceptual-to-empirical approaches, dimensions and characteristics were identified. The taxonomy was validated through the Delphi consensus approach and classifying 20 sample medication adherence technologies and evaluated by mapping to codes identified from a qualitative study.

Results: After undergoing 8 iterations, which included incorporating feedback from a Delphi consensus survey, the final taxonomy comprised 7 dimensions, 25 subdimensions, and 320 characteristics. These key dimensions include Physical Features, Display, Connectivity, System Alert, Data Collection and Management, Operations, and Integration. The taxonomy was considered complete and valuable once all preestablished ending conditions were met, and its applicability and comprehensiveness were verified by comparing various medication adherence technologies and mapping to codes identified from a qualitative study.

Conclusion: This study successfully establishes the first comprehensive classification system for medication adherence technologies based on features, addressing a critical gap in literature. The taxonomy provides a structured framework for categorizing and evaluating technologies, supporting usability testing and the selection of appropriate devices tailored to the unique needs of older adults.

PubMed Disclaimer

Conflict of interest statement

Dr Patel reports grants from National Research Council (NRC), Canadian Institutes of Health Research, Jones Healthcare Group, and Catalyst Health; travel support from National Research Council (NRC) and Canadian Institutes of Health Research; and contribution of medical adherence technology from Jones Healthcare Group and Catalyst Health. The other authors report no competing interests.

Figures

Figure
Figure
Final classification system for medication adherence technologies. GPS, global positioning system; IT, information technology.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. World population prospects 2022: ten key messages United Nations, Department of Economic and Social Affairs, Population Division. https://population.un.org/wpp/
    1. Zheng X., Guo C. Strengthening systematic research on aging: Reflections from an omics perspective. China CDC Wkly. 2022;4(39):875–878. doi: 10.46234/ccdcw2022.181. - DOI - PMC - PubMed
    1. World report on ageing and health World Health Organization. https://www.who.int/publications/i/item
    1. van Riet-Nales D.A., Hussain N., Sundberg K.A., et al. Regulatory incentives to ensure better medicines for older people: from ICH E7 to the EMA reflection paper on quality aspects. Int J Pharm. 2016;512(2) doi: 10.1016/j.ijpharm.2016.05.001. 343-251. - DOI - PubMed
    1. Drenth-van Maanen A.C., Wilting I., Jansen P.A.F. Prescribing medicines to older people—how to consider the impact of ageing on human organ and body functions. Br J Clin Pharmacol. 2020;86(10):1921–1930. doi: 10.1111/bcp.14094. - DOI - PMC - PubMed

LinkOut - more resources